Rating
Innovation
Pricing
Technology
Usability
We have discovered similar tools to what you are looking for. Check out our suggestions for similar AI tools.
Cerebras stock nearly doubles on day one as AI chipmaker hits $100 billion — what it means for AI infrastructure
Cerebras Systems, the Silicon Valley chipmaker that built the world's largest commercial AI processor, erupted onto the Nasdaq on Wednesday, opening at $350 per share — nearly double its $185 I [...]
FDA approves at-home pap smear alternative device for cervical cancer screening
The Food and Drug Administration has approved a new device called the Teal Wand, which its creator describes as an "at-home vaginal sample self-collection device for cervical cancer screening.&qu [...]
Anthropic launches Claude Sonnet 5 at a steep discount to its top model as the company races toward a blockbuster IPO
Anthropic today released Claude Sonnet 5, a new AI model that the company says delivers near-flagship performance at mid-tier prices — a move designed to give cost-conscious enterprise developers ac [...]
Volvo EX60 SUV preview: 400-mile range, 670 hp and Google Gemini onboard
Volvo hasn't exactly had a great run of EVs lately. The rollout of its flagship EX90 was stymied out of the gate by a bevy of software glitches. The EX30, meanwhile, was too expensive when it lau [...]
Awesome Games Done Quick raises another $2.5 million for a cancer nonprofit
The weeklong speedrunning marathon Awesome Games Done Quick 2025 wrapped up in the wee hours of Sunday morning, and organizers say it managed to pull in a total of $2,556,305 for Prevent Cancer Founda [...]
Akeso’s lung cancer drug reduces death risk by 34%, marking the first Chinese drug at ASCO’s top stage in 61 years
Akeso, the Chinese biotechnology company whose drug ivonescimab was dubbed “biotech’s DeepSeek moment” last year, has reported phase three clinical trial results showing a 34% reduction in the r [...]
Stanford researchers will discuss their agentic 'scientists' that are on course to reshape drug discovery at VB Transform 2026
Drug discovery is notoriously inefficient. Pharmaceutical projects span years, moving from one specialized human team to the next through disconnected workflows that result in knowledge loss during ea [...]